CUTR News and Press, Cutera Inc. From 03/25/22

Cutera (NASDAQ:CUTR) said the U.S. Food and Drug Administration granted 510(k) clearance to AviClear to treat mild, moderate and severe Acne. The company said AviClear is the first and only energy-based device to receive this designation for treating mild, moderate, and severe acne....

AviClear is the First Device Cleared for the Treatment of Mild, Moderate and Severe Acne AviClear has been Proven Safe and Effective Through an Extensive Clinical Trial Provides Long-term Resolution of Acne Across All Skin Types CUTERA, INC. (Nasdaq: CUTR) ("Cutera" or t...

Cutera, Inc. (NASDAQ: CUTR ) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that Dave Mowry, Chief Executive Officer, will participate in the Aesthetic Device ...

FORT MILL, S.C., March 01, 2022 (GLOBE NEWSWIRE) -- Diversey Holdings, Ltd. (NASDAQ: DSEY), a leading provider of hygiene, infection prevention and cleaning solutions, has appointed Katherine S. Zanotti to the company’s board of directors, effective March 1, 2022. This appointment wi...

Cutera (CUTR +10.0%) has added more than a tenth to its market cap on Wednesday after the maker of laser hair removal systems reported a strong revenue beat with its Q4 2021 financials. Driven mainly by ~56% YoY growth in the North American Capital Equipment division, revenue for the quarter ...

Cutera, Inc. (CUTR) Q4 2021 Earnings Conference Call February 22, 2022, 4:30 PM ET Company Participants Dave Mowry - Chief Executive Officer Rohan Seth - Chief Financial Officer Conference Call Participants Jon Block - Stifel Chris Cooley - Stephens Louise Chen - Cantor Presentation Operator ...

Image source: The Motley Fool. Cutera (NASDAQ: CUTR) Q4 2021 Earnings Call Feb 22, 2022 , 4:30 p.m. ET Operator Continue reading For further details see: Cutera (CUTR) Q4 2021 Earnings Call Transcript

Cutera  press release (NASDAQ:CUTR): Q4 GAAP EPS of -$0.22 misses by $0.20. Revenue of $65.6M (+31.5% Y/Y) beats by $4.82M. For further details see: Cutera  GAAP EPS of -$0.22 misses by $0.20, revenue of $65.6M beats by $4.82M

Achieved Record Revenue in Fourth Quarter and Full-Year 2021 Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today reported financial result...

Arenberg Capital initiates coverage of InMode stock with hold rating prior to the company's FY21 earnings on February 10, 2022. We ran multiple approaches to determine the fair valuation of this high-growth medtech company. Our DCF indicates a fair valuation at the current price l...